Picture of Valerio Therapeutics SA logo

ALVIO — Valerio Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Onxeo Receives EPO Intent-to-Grant Notice for New Patent Protecting AsiDNA in Combination with Any PARP Inhibitor

Dec 18 (Reuters) - Onxeo SA  C4X.PA :
    * ONXEO RECEIVES EPO INTENT-TO-GRANT NOTICE FOR NEW PATENT
PROTECTING ASIDNA™ IN COMBINATION WITH ANY PARP INHIBITOR
    * COMBINATION PATENT TO BE GRANTED IN EUROPE UNTIL 2036

Source text for Eikon:  ID:nBw4PmLNna 
Further company coverage:  C4X.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Valerio Therapeutics SA

See all news